Radioembolization
Showing 1 - 25 of 158
Transarterial Radioembolization in COlorectal MEtastasis of
Not yet recruiting
- Transarterial Radioembolization
- Therasphere
- (no location specified)
Sep 7, 2023
Hypoxia Before Radioembolization Treatment With 18F-FMISO PET
Recruiting
- Radioembolization
- +3 more
- 18F-Fluoromisonidazole PET
-
Ankara, TurkeyAnkara University
Sep 7, 2023
Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))
Not yet recruiting
- Hepatocellular Carcinoma (HCC)
- Durvalumab
- +2 more
- (no location specified)
Sep 11, 2023
Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)
Recruiting
- Liver Metastases
- Breast Cancer
- Quiremspheres™
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Nov 16, 2023
Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)
Not yet recruiting
- Carcinoma, Hepatocellular
- Therasphere 90Y
- Microwave Ablation
- (no location specified)
Jul 12, 2023
Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- EYE90 Microspheres Treatment
- (no location specified)
Jul 12, 2023
Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)
Active, not recruiting
- Hepatocellular Carcinoma
- Radioembolization using Holmium-166
-
Brussels, Anderlecht, BelgiumHôpital Universitaire Erasme, ULB
Dec 7, 2022
Hepatocellular Carcinoma Non-resectable Trial (Holmium-166 radioembolization)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Holmium-166 radioembolization
-
Utrecht, NetherlandsUMC Utrecht
Nov 7, 2022
Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)
Not yet recruiting
- Primary Liver Cancer
- Non-Resectable Hepatocellular Carcinoma
- MRI-guided radioembolization
- (no location specified)
Nov 1, 2022
Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,
Not yet recruiting
- Resectable Hepatocellular Carcinoma
- +2 more
- Durvalumab
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 18, 2023
Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)
Recruiting
- Thrombocytopenia
- Cirrhosis
- TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
-
Chicago, IllinoisNorthwestern University/Northwestern Memorial Hospital
Sep 7, 2022
HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)
Active, not recruiting
- HepatoCellular Carcinoma
- Y-90 Radioembolization
- Nivolumab
-
Singapore, SingaporeNational Cancer Centre - Singapore
May 25, 2022
Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic
Not yet recruiting
- Locally Advanced Intrahepatic Cholangiocarcinoma
- +4 more
- Angiography
- +8 more
-
Jacksonville, FloridaMayo Clinic in Florida
Sep 22, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Y-90 SIR-Spheres
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 7, 2022
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Hepatocellular Carcinoma Trial (Holmium-166 treatment, Holmium-166 work-up)
Not yet recruiting
- Hepatocellular Carcinoma
- Holmium-166 treatment
- Holmium-166 work-up
- (no location specified)
Jul 6, 2022
Biopsy After Radioembolization to Identify Changes in Tumor
Recruiting
- Colon Cancer Liver Metastasis
- +5 more
- Y90 TARE
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 30, 2022
Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)
Completed
- Colon Cancer
- +2 more
- Tas-102
- SIR-Sphere
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 28, 2022
Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and
Not yet recruiting
- Hepatocellular Carcinoma
- Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
- Atezolizumab and bevacizumab
- transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
-
Dallas, TexasSimmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022
Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer Trial in Boston (Standard microcatheter, PEDD device)
Recruiting
- Liver Cancer
- +2 more
- Standard microcatheter
- PEDD device
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
May 17, 2022
Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90
Recruiting
- Colorectal Cancer Metastatic
- +9 more
- Durvalumab
- Yttrium-90 RadioEmbolization
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Mar 24, 2022
Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- Neuroendocrine Neoplasm
- Arterial Embolization
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 22, 2022
Colorectal Cancer Metastatic Trial (radioembolization, Standard of care first-line systemic therapy)
Not yet recruiting
- Colorectal Cancer Metastatic
- radioembolization
- Standard of care first-line systemic therapy
- (no location specified)
Oct 26, 2021
Hepatocellular Carcinoma Trial in Philadelphia (Yttrium-90 Microsphere Radioembolization, Perflutren Protein-Type A
Recruiting
- Hepatocellular Carcinoma
- Yttrium-90 Microsphere Radioembolization
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022